Advanced Materials · 2023 · 21 citations · 20 references
MedicineOncologyPharmacologyApoptosisCancer ImmunologyImmunotherapyAnticancer Prodrug DesignAntitumor T Cell ResponsesCancer ImmunotherapyCytotoxic ChemotherapyImmunotherapy For Breast CancerIntegrin SignalingCancer Cell ApoptosisChemotherapy-induced Immunogenic Cell DeathFas LigandImmunogenic Cell Death InductionPeptide-drug ConjugatesPeptide-linked ProdrugsTriple-negative Breast Cancer ImmunotherapyTumor-targeting Peptides
Abstract Tumor‐associated endothelial cells (TECs) limit antitumor immunity via inducing apoptosis of infiltrating T lymphocytes through a Fas ligand (FasL) mediated mechanism. Herein, this work creates a peptide‐drug conjugate (PDC) by linking 7‐ethyl‐10‐hydroxycamptothecin (SN38) to hydrophilic segments with either RGDR or HKD motif at their C‐terminus through a glutathione‐responsive linker. The PDCs spontaneously assemble into filaments in aqueous solution. The PDC filaments containing 1% of SN38‐RGDR (SN38‐HKD/RGDR) effectively target triple‐negative breast cancer (TNBC) cells and TECs with upregulated expression of integrin, and induce immunogenic cell death (ICD) of tumor cells and FasL downregulation of TECs. SN38‐HKD/RGDR increases infiltration, activity, and viability of CD8 + T cells, and thus inhibits the growth of primary tumors and pulmonary metastasis. This study highlights the synergistic modulation of cancerous cells and TECs with integrin‐targeting PDC filaments as a promising strategy for TNBC chemoimmunotherapy.
20
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
Peter Schmid, Sylvia Adams, Hope S. Rugo et al. · New England Journal of Medicine · 2018 · 4.4K citations · Full text
Medicine, Oncology, Pharmacology +17
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
Aditya Bardia, Sara A. Hurvitz, Sara M. Tolaney et al. · New England Journal of Medicine · 2021 · 1.5K citations · Full text
Medicine, Oncology, Pharmacology +17
Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors
Gregory T. Motz, Stephen P. Santoro, Liping Wang et al. · Nature Medicine · 2014 · 1K citations · Full text
Medicine, Immunology, Oncology +14
Magnetic Iron Oxide Nanoworms for Tumor Targeting and Imaging
Ji‐Ho Park, Geoffrey von Maltzahn, Lianglin Zhang et al. · Advanced Materials · 2008 · 552 citations · Full text
Pharmacy, Oncology, Pharmaceutics +17